Sign in

A/Prof Mastura Monif

@masturamonif.bsky.social
39 followers 39 following 2 posts

Neurologist / Neuroimmunologist Neuroscientist

PostsRepliesMedia
Reposted by A/Prof Mastura Monif
Department of Neuroscience @monashstmneuro.bsky.social · 19/09/2025
NEW in @plosone.org promising #glioblastoma therapeutic target. Dr Matthew Drill & team @masturamonif.bsky.social @monashuniversity.bsky.social reveal an alternative pathway with selective targeting to complement existing treatments and/or offer new treatment doi.org/10.1371/jour... #neuroscience
doi.org
Purinergic P2X receptor 7 (P2X7R) inhibition induced cytotoxicity in glioblastoma
Glioblastoma is the most common and aggressive form of primary brain cancer with a median survival of 15 months from diagnosis. The purinergic receptor P2X7 (P2X7R) is a regulator of several cell sign...
031
A/Prof Mastura Monif @masturamonif.bsky.social · 18/04/2025
Our public webinar Living with #Autoimmune #Encephalitis is now available on YouTube. Thanks to Amber, Amanda & Michelle for their enormous courage to share their lived experiences of AE. I am sure the stories will resonate with many others. @monashstm-grsc.bsky.social youtu.be/S2B4fe7CwK0?...
youtu.be
Living with Autoimmune Encephalitis
YouTube video by Translational Medicine, Monash University
020
A/Prof Mastura Monif @masturamonif.bsky.social · 01/03/2025
#AutoimmuneEncephalitis can induce longlasting and pervasive impacts. On Tuesday 11th of March, we are hosting a webinar featuring those with lived experiences of AE. Link below to register: events.humanitix.com/understandin...
events.humanitix.com
Living with Autoimmune Encephalitis
Learn about autoimmune encephalitis & hear personal stories of coping & thriving while living with this rare condition.
001
Reposted by A/Prof Mastura Monif
A/Prof Anneke van der Walt @annekevdw.bsky.social · 17/12/2024
Does progression occur independent of relapses (#PIRA) in neuromyelitis optica (#NMOSD)? Our PhD student Pakeeran Siriratnam examined this in real-world data & by tracking data on each progression event. @masturamonif.bsky.social @vjokubaitis.bsky.social www.neurology.org/doi/10.1212/...
neurology.org
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG–Positive NMOSD | Neurology
ObjectivesIn aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess the prevalence of pr...
041
Reposted by A/Prof Mastura Monif
A/Prof Anneke van der Walt @annekevdw.bsky.social · 17/12/2024
Alfred Health MSNI with Alfred Haematology is proud and excited to be one of two sites in Australia to offer #CARTcell therapy for aggressive relapsing and also progressive forms of #MS. @masturamonif.bsky.social jamanetwork.com/journals/jam...
jamanetwork.com
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology
This narrative review explores the current and future roles of chimeric antigen receptor (CAR) T-cell therapy in neurology, particularly for primary brain tumors and autoimmune neurological disorders.
041